Another example is VG-3927 (NCT06343636), a novel small-molecule TREM2 agonist capable of crossing the blood-brain barrier and efficiently activating TREM2 downstream signaling pathways to modulate the function of microglia, for the treatment of AD (149). Here, TREM2 is linked to Alzheimer disease.